EDGAR Filing Documents for 0001683168-20-000556

Form 1-A/A - Offering Statement [Regulation A]: [Amend]

SEC Accession No. 0001683168-20-000556

Filing Date

2020-02-21

Accepted

2020-02-21 09:39:16

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	1-A/A
1		primary_doc.xml	1-A/A	5899
2	PART II AND III	cbd_1aa7.htm	PART II AND III	1813747
3	CERTIFICATE OF AMENDMENT TO RESTATED ARTICLES OR AMENDED AND RESTATED ARTICLES	cbd_ex0204.htm	EX1A-2A CHARTER	6924
4	GRAPHIC	logo.jpg	GRAPHIC	34896
5	GRAPHIC	image_001.jpg	GRAPHIC	9809
6	GRAPHIC	image_002.jpg	GRAPHIC	2543
7	GRAPHIC	image_005.jpg	GRAPHIC	3173
8	GRAPHIC	image_003.jpg	GRAPHIC	4722
9	GRAPHIC	image_006.jpg	GRAPHIC	371364
10	GRAPHIC	image_010.jpg	GRAPHIC	319902
11	GRAPHIC	image_008.jpg	GRAPHIC	33391
12	GRAPHIC	image_009.jpg	GRAPHIC	235340
	Complete submission text file	0001683168-20-000556.txt		3226931

Mailing Address 10855 N. 116TH STREET, SUITE 115 SCOTTSDALE AZ 85259

Business Address 10855 N. 116TH STREET, SUITE 115 SCOTTSDALE AZ 85259 480-410-6780

CBD Life Sciences Inc. (Filer) CIK: 0001776073 (see all company filings)